Product Information
CAPTOPRIL 25 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1728 per EA under NDC 31722014201. Its NADAC has been published 247 times since Jan 12, 2022.
FDA first approved this application on Oct 28, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722014201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CAPTOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA074737FDA Approved
10/28/1998
TE Code
AB
On Market Since
12/7/2005
Pharmacological Classes
Price Statistics
The NADAC for CAPTOPRIL 25 MG TABLET has been published 247 times since Jan 12, 2022, and over the history we have for it it has declined 70.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1728 per EA |
|---|---|
| All-time high | $0.6194 (May 11, 2022) |
| All-time low | $0.1060 (Aug 20, 2025) |
| 52-week high | $0.1826 |
| 52-week low | $0.1178 |
| Median price | $0.2880 |
| Average price | $0.3155 |
| Largest weekly change | +109.0% (May 17, 2023) |
| Weeks tracked | 247 |
| Tracking since | Jan 12, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Captopril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CAPTOPRIL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPTOPRIL 25 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1728 per EA (NDC 31722014201), effective Sep 30, 2026.
How has the price of CAPTOPRIL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPTOPRIL 25 MG TABLET has declined 70.1%. It has been tracked across 247 weekly CMS publications since Jan 12, 2022.
What are the highest and lowest recorded NADAC prices for CAPTOPRIL 25 MG TABLET?
Since Jan 12, 2022, the NADAC for CAPTOPRIL 25 MG TABLET has ranged from a low of $0.1060 (Aug 20, 2025) to a high of $0.6194 (May 11, 2022), with a median of $0.2880 per EA.
Are there cheaper alternatives to CAPTOPRIL 25 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CAPTOPRIL 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CAPTOPRIL 25 MG TABLET?
CAPTOPRIL 25 MG TABLET (NDC 31722014201) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.